Announcements Trials
Browse Landscape

Phase

Phase 1 9Phase 2 7Phase NA 2Phase 3 1

Status

Completed 4Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

CNS 2Tumor-Agnostic 1Thoracic 1Other hematologic neoplasm 1Gastrointestinal 1Dermatologic 1

Conditions

Neuroblastoma 2Pancreatic Neoplasms 1Neoplasms 1Melanoma 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 901Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 433Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2 × saponin QA-21V1 × Clear all
NCT06057948 2026-06-05

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
94 enrolled
CNS

Neuroblastoma

NCT04936529 2026-05-07

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
286 enrolled
CNS

Neuroblastoma

NCT05638698 2024-09-23

TESLA

University of Kansas Medical Center

Phase 2 Active not recruiting
24 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00579423 2023-10-05

Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
30 enrolled
Tumor-Agnostic

Neoplasms

NCT00003362 2013-06-25

Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
Dermatologic

Melanoma

NCT00004052 2013-06-25

Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
24 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Chronic-Phase

NCT00004249 2013-06-19

Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡